Transforming growth factor-beta messenger RNA and protein in murine colitis

C V Whiting, A M Williams, M H Claesson, S Bregenholt, J Reimann, P W Bland

Research output: Contribution to journalArticle (Academic Journal)peer-review


Using a CD4+ T-cell-transplanted SCID mouse model of colitis, we have analyzed TGF-beta transcription and translation in advanced disease. By in situ hybridization, the epithelium of both control and inflamed tissues transcribed TGF-beta1 and TGF-beta3 mRNAs, but both were expressed significantly farther along the crypt axis in disease. Control lamina propria cells transcribed little TGF-beta1 or TGF-beta3 mRNA, but in inflamed tissues many cells expressed mRNA for both isoforms. No TGF-beta2 message was detected in either control or inflamed tissues. Immunohistochemistry for latent and active TGF-beta1 showed that all cells produced perinuclear latent TGF-beta1. The epithelial cell basal latent protein resulted in only low levels of subepithelial active protein, which co-localized with collagen IV and laminin in diseased and control tissue. Infiltrating cells expressed very low levels of active TGF-beta. By ELISA, very low levels (0-69 pg/mg) of soluble total or active TGF-beta were detected in hypotonic tissue lysates. TGF-beta1 and TGF-beta3 are produced by SCID mouse colon and transcription is increased in the colitis caused by transplantation of CD4+ T-cells, but this does not result in high levels of soluble active protein. Low levels of active TGF-beta may be a factor contributing to unresolved inflammation.
Original languageEnglish
Pages (from-to)727-38
Number of pages12
JournalJournal of Histochemistry and Cytochemistry
Issue number6
Publication statusPublished - 2001


Dive into the research topics of 'Transforming growth factor-beta messenger RNA and protein in murine colitis'. Together they form a unique fingerprint.

Cite this